Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD.
APA
Wu G, Zhang GM (2026). Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD.. Gut. https://doi.org/10.1136/gutjnl-2026-338222
MLA
Wu G, et al.. "Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD.." Gut, 2026.
PMID
41617488
같은 제1저자의 인용 많은 논문 (5)
- No-touch versus conventional radiofrequency ablation for treating solitary recurrent hepatocellular carcinoma ≤ 3 cm: a retrospective cohort study.
- Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
- Globus pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a retrospective study on short- and long-term efficacy.
- Long-Term Outcome of No-Touch Radiofrequency Ablation for Treating AFP-Positive Small Hepatocellular Carcinoma.
- [Retracted] Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.